{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T17:10:01Z","timestamp":1790183401686,"version":"4.1.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2012,1,24]],"date-time":"2012-01-24T00:00:00Z","timestamp":1327363200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Neuropathol"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1007\/s00401-012-0943-2","type":"journal-article","created":{"date-parts":[[2012,1,23]],"date-time":"2012-01-23T01:32:26Z","timestamp":1327282346000},"page":"433-447","source":"Crossref","is-referenced-by-count":77,"title":["Early AD pathology in a [C-11]PiB-negative case: a PiB-amyloid imaging, biochemical, and immunohistochemical study"],"prefix":"10.1007","volume":"123","author":[{"given":"Milos D.","family":"Ikonomovic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric E.","family":"Abrahamson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie C.","family":"Price","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald L.","family":"Hamilton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chester A.","family":"Mathis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William R.","family":"Paljug","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manik L.","family":"Debnath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne D.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuyoshi","family":"Mizukami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven T.","family":"DeKosky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar L.","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William E.","family":"Klunk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,1,24]]},"reference":[{"key":"943_CR1","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1001\/archneur.65.11.1509","volume":"65","author":"HJ Aizenstein","year":"2008","unstructured":"Aizenstein HJ, Nebes RD, Saxton JA, Price JC, Mathis CA, Tsopelas ND, Ziolko SK, James JA, Snitz BE, Houck PR, Bi W, Cohen AD, Lopresti BJ, DeKosky ST, Halligan EM, Klunk WE (2008) Frequent amyloid deposition without significant cognitive impairment among the elderly. Arch Neurol 65:1509\u20131517","journal-title":"Arch Neurol"},{"key":"943_CR2","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1001\/archneur.64.3.431","volume":"64","author":"BJ Bacskai","year":"2007","unstructured":"Bacskai BJ, Frosch MP, Freeman SH, Raymond SB, Augustinack JC, Johnson KA, Irizarry MC, Klunk WE, Mathis CA, DeKosky ST, Hyman BT, Growdon JH (2007) Molecular imaging with Pittsburgh Compound B confirmed at autopsy: a case report. Arch Neurol 64:431\u2013434","journal-title":"Arch Neurol"},{"key":"943_CR3","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1093\/cercor\/4.2.138","volume":"4","author":"C Bouras","year":"1994","unstructured":"Bouras C, Hof PR, Giannakopoulos P, Michel JP, Morrison JH (1994) Regional distribution of neurofibrillary tangles and senile plaques in the cerebral cortex of elderly patients: a quantitative evaluation of a one-year autopsy population from a geriatric hospital. Cereb Cortex 4:138\u2013150","journal-title":"Cereb Cortex"},{"key":"943_CR4","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0197-4580(97)00056-0","volume":"18","author":"H Braak","year":"1997","unstructured":"Braak H, Braak E (1997) Frequency of stages of Alzheimer-related lesions in different age categories. Neurobiol Aging 18:351\u2013357","journal-title":"Neurobiol Aging"},{"key":"943_CR5","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1212\/WNL.0b013e3181c7da8e","volume":"74","author":"MA Burack","year":"2010","unstructured":"Burack MA, Hartlein J, Flores HP, Taylor-Reinwald L, Perlmutter JS, Cairns NJ (2010) In vivo amyloid imaging in autopsy-confirmed Parkinson disease with dementia. Neurology 74:77\u201384","journal-title":"Neurology"},{"key":"943_CR6","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1001\/archneurol.2009.279","volume":"66","author":"NJ Cairns","year":"2009","unstructured":"Cairns NJ, Ikonomovic MD, Benzinger T, Storandt M, Fagan AM, Shah A, Schmidt RE, Perry A, Reinwald LT, Carter D, Felton A, Holtzman DM, Mintun MA, Klunk WE, Morris JC (2009) Absence of PIttsburgh Compound B detection of cerebral amyloid beta in a patient with clinical, cognitive, and cerebrospinal fluid markers of Alzheimer disease. Arch Neurol 66:1557\u20131562","journal-title":"Arch Neurol"},{"key":"943_CR7","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1212\/WNL.49.1.70","volume":"49","author":"CM Clark","year":"1997","unstructured":"Clark CM, Ewbank D, Lerner A, Doody R, Henderson VW, Panisset M, Morris JC, Fillenbaum GG, Heyman A (1997) The relationship between extrapyramidal signs and cognitive performance in patients with Alzheimer\u2019s disease enrolled in the CERAD Study. Consortium to Establish a Registry for Alzheimer\u2019s Disease. Neurology 49:70\u201375","journal-title":"Neurology"},{"key":"943_CR8","unstructured":"Consensus (1998) Consensus report of the Working Group on \u201cMolecular and Biochemical Markers of Alzheimer\u2019s Disease\u201d. The Ronald and Nancy Reagan Research Institute of the Alzheimer\u2019s Association and the National Institute on Aging Working Group. Neurobiol Aging 19:109\u2013116"},{"key":"943_CR9","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1212\/WNL.38.11.1688","volume":"38","author":"L Davies","year":"1988","unstructured":"Davies L, Wolska B, Hilbich C, Multhaup G, Martins R, Simms G, Beyreuther K, Masters CL (1988) A4 amyloid protein deposition and the diagnosis of Alzheimer\u2019s disease: prevalence in aged brains determined by immunocytochemistry compared with conventional neuropathologic techniques. Neurology 38:1688\u20131693","journal-title":"Neurology"},{"key":"943_CR10","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/00005072-199704000-00001","volume":"56","author":"DW Dickson","year":"1997","unstructured":"Dickson DW (1997) The pathogenesis of senile plaques. J Neuropathol Exp Neurol 56:321\u2013339","journal-title":"J Neuropathol Exp Neurol"},{"key":"943_CR11","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/NEN.0b013e31817d7a1d","volume":"67","author":"H Fujishiro","year":"2008","unstructured":"Fujishiro H, Ferman TJ, Boeve BF, Smith GE, Graff-Radford NR, Uitti RJ, Wszolek ZK, Knopman DS, Petersen RC, Parisi JE, Dickson DW (2008) Validation of the neuropathologic criteria of the third consortium for dementia with Lewy bodies for prospectively diagnosed cases. J Neuropath Exp Neurol 67:649\u2013656","journal-title":"J Neuropath Exp Neurol"},{"key":"943_CR12","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1006\/bbrc.2000.3490","volume":"276","author":"Y Harigaya","year":"2000","unstructured":"Harigaya Y, Saido TC, Eckman CB, Prada CM, Shoji M, Younkin SG (2000) Amyloid beta protein starting pyroglutamate at position 3 is a major component of the amyloid deposits in the Alzheimer\u2019s disease brain. Biochem Biophys Res Commun 276:422\u2013427","journal-title":"Biochem Biophys Res Commun"},{"key":"943_CR13","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1001\/archneur.55.9.1185","volume":"55","author":"V Haroutunian","year":"1998","unstructured":"Haroutunian V, Perl DP, Purohit DP, Marin D, Khan K, Lantz M, Davis KL, Mohs RC (1998) Regional distribution of neuritic plaques in the nondemented elderly and subjects with very mild Alzheimer disease. Arch Neurol 55:1185\u20131191","journal-title":"Arch Neurol"},{"key":"943_CR14","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1212\/WNL.17.5.427","volume":"17","author":"MM Hoehn","year":"1967","unstructured":"Hoehn MM, Yahr MD (1967) Parkinsonism: onset, progression, and mortality. Neurology 17:427\u2013442","journal-title":"Neurology"},{"key":"943_CR15","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0076-6879(06)12009-1","volume":"412","author":"MD Ikonomovic","year":"2006","unstructured":"Ikonomovic MD, Abrahamson EE, Isanski BA, Debnath ML, Mathis CA, DeKosky ST, Klunk WE (2006) X-34 labeling of abnormal protein aggregates during the progression of Alzheimer\u2019s disease. Methods Enzymol 412:123\u2013144","journal-title":"Methods Enzymol"},{"key":"943_CR16","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1093\/brain\/awn016","volume":"131","author":"MD Ikonomovic","year":"2008","unstructured":"Ikonomovic MD, Klunk WE, Abrahamson EE, Mathis CA, Price JC, Tsopelas ND, Lopresti BJ, Ziolko S, Bi W, Paljug WR, Debnath ML, Hope CE, Isanski BA, Hamilton RL, DeKosky ST (2008) Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer\u2019s disease. Brain 131:1630\u20131645","journal-title":"Brain"},{"key":"943_CR17","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1093\/brain\/awq349","volume":"134","author":"A Kadir","year":"2011","unstructured":"Kadir A, Marutle A, Gonzalez D, Sch\u00f6ll M, Almkvist O, Mousavi M, Mustafiz T, Darreh-Shori T, Nennesmo I, Nordberg A (2011) Positron emission tomography imaging and clinical progression in relation to molecular pathology in the first Pittsburgh Compound B positron emission tomography patient with Alzheimer\u2019s disease. Brain 134:301\u2013317","journal-title":"Brain"},{"key":"943_CR18","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/414643a","volume":"414","author":"A Kamal","year":"2001","unstructured":"Kamal A, Almenar-Queralt A, LeBlanc JF, Roberts EA, Goldstein LS (2001) Kinesin-mediated axonal transport of a membrane compartment containing beta-secretase and presenilin-1 requires APP. Nature 414:643\u2013648","journal-title":"Nature"},{"key":"943_CR19","unstructured":"Kantarci K, Yang C, Schneider JA, Senjem ML, Reyes DA, Lowe VJ, Barnes LL, Aggarwal NT, Bennett DA, Smith GE, Petersen RC, Jack CRJ, Boeve BF (2010) Ante mortem amyloid imaging and \u03b2-amyloid pathology in a case with dementia with Lewy bodies. Neurobiol Aging [Epub ahead of print]"},{"key":"943_CR20","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1001\/archneur.1985.04060100083029","volume":"42","author":"ZS Khachaturian","year":"1985","unstructured":"Khachaturian ZS (1985) Diagnosis of Alzheimer\u2019s disease. Arch Neurol 42:1097\u20131105","journal-title":"Arch Neurol"},{"key":"943_CR21","first-page":"121","volume":"2","author":"KS Kim","year":"1988","unstructured":"Kim KS (1988) Production and characterization of monoclonal antibodies reactive to synthetic cerebrovascular amyloid peptide. Neurosci Res Comm 2:121\u2013130","journal-title":"Neurosci Res Comm"},{"key":"943_CR22","first-page":"113","volume":"7","author":"K Kim","year":"1990","unstructured":"Kim K, Wen G, Bancher C et al (1990) Detection and quantitation of \u03b2-peptide with two monoclonal antibodies. Neurosci Res Commun 7:113\u2013122","journal-title":"Neurosci Res Commun"},{"key":"943_CR23","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1016\/S0024-3205(01)01232-2","volume":"69","author":"WE Klunk","year":"2001","unstructured":"Klunk WE, Wang Y, Huang GF, Debnath ML, Holt DP, Mathis CA (2001) Uncharged thioflavin-T derivatives bind to amyloid-beta protein with high affinity and readily enter the brain. Life Sci 69:1471\u20131484","journal-title":"Life Sci"},{"key":"943_CR24","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/ana.20009","volume":"55","author":"WE Klunk","year":"2004","unstructured":"Klunk WE, Engler H, Nordberg A, Wang Y, Blomqvist G, Holt DP, Bergstrom M, Savitcheva I, Huang GF, Estrada S, Ausen B, Debnath ML, Barletta J, Price JC, Sandell J, Lopresti BJ, Wall A, Koivisto P, Antoni G, Mathis CA, Langstrom B (2004) Imaging brain amyloid in Alzheimer\u2019s disease with Pittsburgh Compound-B. Ann Neurol 55:306\u2013319","journal-title":"Ann Neurol"},{"key":"943_CR25","doi-asserted-by":"crossref","first-page":"33623","DOI":"10.1074\/jbc.271.52.33623","volume":"271","author":"M Lalowski","year":"1996","unstructured":"Lalowski M, Golabek A, Lemere CA, Selkoe DJ, Wisniewski HM, Beavis RC, Frangione B, Wisniewski T (1996) The \u201cnonamyloidogenic\u201d p3 fragment (amyloid beta17\u201342) is a major constituent of Down\u2019s syndrome cerebellar preamyloid. J Biol Chem 271:33623\u201333631","journal-title":"J Biol Chem"},{"key":"943_CR26","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1001\/archneur.65.10.noc80013","volume":"65","author":"V Leinonen","year":"2008","unstructured":"Leinonen V, Alafuzoff I, Aalto S, Suotunen T, Savolainen S, N\u00e5gren K, Tapiola T, Pirttil\u00e4 T, Rinne J, J\u00e4\u00e4skel\u00e4inen JE, Soininen H, Rinne JO (2008) Assessment of beta-amyloid in a frontal cortical brain biopsy specimen and by positron emission tomography with carbon 11-labeled Pittsburgh Compound B. Arch Neurol 65:1304\u20131309","journal-title":"Arch Neurol"},{"key":"943_CR27","doi-asserted-by":"crossref","unstructured":"Lockhart A, Lamb JR, Osredkar T, Sue LI, Joyce JN, Ye L, Libri V, Leppert D, Beach TG (2007) PIB is a non-specific imaging marker of amyloid-beta (Abeta) peptide-related cerebral amyloidosis. Brain 130:2607\u20132615","DOI":"10.1093\/brain\/awm191"},{"key":"943_CR28","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1097\/00004647-199609000-00008","volume":"16","author":"J Logan","year":"1996","unstructured":"Logan J, Fowler JS, Volkow ND, Wang GJ, Ding YS, Alexoff DL (1996) Distribution volume ratios without blood sampling from graphical analysis of PET data. J Cereb Blood Flow Metab 16:834\u2013840","journal-title":"J Cereb Blood Flow Metab"},{"key":"943_CR29","first-page":"1959","volume":"46","author":"BJ Lopresti","year":"2005","unstructured":"Lopresti BJ, Klunk WE, Mathis CA, Hoge JA, Ziolko SK, Lu X, Meltzer CC, Schimmel K, Tsopelas ND, DeKosky ST, Price JC (2005) Simplified quantification of Pittsburgh Compound B amyloid imaging PET studies: a comparative analysis. J Nucl Med 46:1959\u20131972","journal-title":"J Nucl Med"},{"key":"943_CR30","doi-asserted-by":"crossref","first-page":"10957","DOI":"10.1523\/JNEUROSCI.0673-07.2007","volume":"27","author":"J Maeda","year":"2007","unstructured":"Maeda J, Ji B, Irie T, Tomiyama T, Maruyama M, Okauchi T, Staufenbiel M, Iwata N, Ono M, Saido TC, Suzuki K, Mori H, Higuchi M, Suhara T (2007) Longitudinal, quantitative assessment of amyloid, neuroinflammation, and anti-amyloid treatment in a living mouse model of Alzheimer\u2019s disease enabled by positron emission tomography. J Neurosci 27:10957\u201310968","journal-title":"J Neurosci"},{"key":"943_CR31","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0960-894X(01)00734-X","volume":"12","author":"CA Mathis","year":"2002","unstructured":"Mathis CA, Bacskai BJ, Kajdasz ST, McLellan ME, Frosch MP, Hyman BT, Holt DP, Wang Y, Huang GF, Debnath ML, Klunk WE (2002) A lipophilic thioflavin-T derivative for positron emission tomography (PET) imaging of amyloid in brain. Bioorg Med Chem Lett 12:295\u2013298","journal-title":"Bioorg Med Chem Lett"},{"key":"943_CR32","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1021\/jm030026b","volume":"46","author":"CA Mathis","year":"2003","unstructured":"Mathis CA, Wang Y, Holt DP, Huang GF, Debnath ML, Klunk WE (2003) Synthesis and evaluation of 11C-labeled 6-substituted 2-arylbenzothiazoles as amyloid imaging agents. J Med Chem 46:2740\u20132754","journal-title":"J Med Chem"},{"key":"943_CR33","doi-asserted-by":"crossref","first-page":"417","DOI":"10.3233\/JAD-2006-9S347","volume":"9","author":"IG McKeith","year":"2006","unstructured":"McKeith IG (2006) Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the Consortium on DLB International Workshop. J Alzheimer Dis 9:417\u2013423","journal-title":"J Alzheimer Dis"},{"key":"943_CR34","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/ana.410150302","volume":"15","author":"MA Mintun","year":"1984","unstructured":"Mintun MA, Raichle ME, Kilbourn MR, Wooten GF, Welch MJ (1984) A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography. Ann Neurol 15:217\u2013227","journal-title":"Ann Neurol"},{"key":"943_CR35","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1212\/01.wnl.0000228230.26044.a4","volume":"67","author":"MA Mintun","year":"2006","unstructured":"Mintun MA, LaRossa GN, Sheline YI, Dence CS, Lee SY, March RH, Klunk WE, Mathis CA, DeKosky ST, Morris JC (2006) [11C]PIB in a nondemented population: potential antecedent marker of Alzheimer disease. Neurology 67:446\u2013452","journal-title":"Neurology"},{"key":"943_CR36","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1212\/WNL.41.4.479","volume":"41","author":"SS Mirra","year":"1991","unstructured":"Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, van Belle G, Berg L (1991) The consortium to establish a registry for Alzheimer\u2019s disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer\u2019s disease. Neurology 41:479\u2013486","journal-title":"Neurology"},{"key":"943_CR37","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/ana.21843","volume":"67","author":"JC Morris","year":"2010","unstructured":"Morris JC, Roe CM, Xiong C, Fagan AM, Goate AM, Holtzman DM, Mintun MA (2010) APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging. Ann Neurol 67:122\u2013131","journal-title":"Ann Neurol"},{"key":"943_CR38","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1038\/sj.jcbfm.9600146","volume":"25","author":"JC Price","year":"2005","unstructured":"Price JC, Klunk WE, Lopresti BJ, Lu X, Hoge JA, Ziolko SK, Holt DP, Meltzer CC, DeKosky ST, Mathis CA (2005) Kinetic modeling of amyloid binding in humans using PET imaging and Pittsburgh Compound-B. J Cereb Blood Flow Metab 25:1528\u20131547","journal-title":"J Cereb Blood Flow Metab"},{"key":"943_CR39","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/1531-8249(199903)45:3<358::AID-ANA12>3.0.CO;2-X","volume":"45","author":"JL Price","year":"1999","unstructured":"Price JL, Morris JC (1999) Tangles and plaques in nondemented aging and \u201cpreclinical\u201d Alzheimer\u2019s disease. Ann Neurol 45:358\u2013368","journal-title":"Ann Neurol"},{"key":"943_CR40","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.neurobiolaging.2009.04.002","volume":"30","author":"JL Price","year":"2009","unstructured":"Price JL, McKeel DWJ, Buckles VD, Roe CM, Xiong C, Grundman M, Hansen LA, Petersen RC, Parisi JE, Dickson DW, Smith CD, Davis DG, Schmitt FA, Markesbery WR, Kaye J, Kurlan R, Hulette C, Kurland BF, Higdon R, Kukull W, Morris JC (2009) Neuropathology of nondemented aging: Presumptive evidence for preclinical Alzheimer disease. Neurobiol Aging 30:1026\u20131036","journal-title":"Neurobiol Aging"},{"key":"943_CR41","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1001\/archneur.65.11.1467","volume":"65","author":"CM Roe","year":"2008","unstructured":"Roe CM, Mintun MA, D\u2019Angelo G, Xiong C, Grant EA, Morris JC (2008) Alzheimer disease and cognitive reserve: variation of education effect with carbon 11-labeled Pittsburgh Compound B uptake. Arch Neurol 65:1467\u20131471","journal-title":"Arch Neurol"},{"key":"943_CR42","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00401-009-0583-3","volume":"119","author":"RF Rosen","year":"2010","unstructured":"Rosen RF, Ciliax BJ, Wingo TS, Gearing M, Dooyema J, Lah JJ, Ghiso JA, LeVine Hr, Walker LC (2010) Deficient high-affinity binding of Pittsburgh compound B in a case of Alzheimer\u2019s disease. Acta Neuropathol 119:221\u2013233","journal-title":"Acta Neuropathol"},{"key":"943_CR43","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1212\/01.wnl.0000261919.22630.ea","volume":"68","author":"CC Rowe","year":"2007","unstructured":"Rowe CC, Ng S, Ackermann U, Gong SJ, Pike K, Savage G, Cowie TF, Dickinson KL, Maruff P, Darby D, Smith C, Woodward M, Merory J, Tochon-Danguy H, O\u2019Keefe G, Klunk WE, Mathis CA, Price JC, Masters CL, Villemagne VL (2007) Imaging beta-amyloid burden in aging and dementia. Neurology 68:1718\u20131725","journal-title":"Neurology"},{"key":"943_CR44","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.neurobiolaging.2010.04.007","volume":"31","author":"CC Rowe","year":"2010","unstructured":"Rowe CC, Ellis KA, Rimajova M, Bourgeat P, Pike KE, Jones G, Fripp J, Tochon-Danguy H, Morandeau L, O\u2019Keefe G, Price R, Raniga P, Robins P, Acosta O, Lenzo N, Szoeke C, Salvado O, Head R, Martins R, Masters CL, Ames D, Villemagne VL (2010) Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging. Neurobiol Aging 31:1275\u20131283","journal-title":"Neurobiol Aging"},{"key":"943_CR45","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/0896-6273(95)90301-1","volume":"14","author":"TC Saido","year":"1995","unstructured":"Saido TC, Iwatsubo T, Mann DM, Shimada H, Ihara Y, Kawashima S (1995) Dominant and differential deposition of distinct beta-amyloid peptide species, A beta N3(pE), in senile plaques. Neuron 14:457\u2013466","journal-title":"Neuron"},{"key":"943_CR46","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1001\/archneurol.2010.357","volume":"68","author":"J Sojkova","year":"2011","unstructured":"Sojkova J, Driscoll I, Iacono D, Zhou Y, Codispoti KE, Kraut MA, Ferrucci L, Pletnikova O, Mathis CA, Klunk WE, O\u2019Brien RJ, Wong DF, Troncoso JC, Resnick SM (2011) In vivo fibrillar beta-amyloid detected using [11C]PiB positron emission tomography and neuropathologic assessment in older adults. Arch Neurol 68:232\u2013240","journal-title":"Arch Neurol"},{"key":"943_CR47","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1177\/002215540004800906","volume":"48","author":"SD Styren","year":"2000","unstructured":"Styren SD, Hamilton RL, Styren GC, Klunk WE (2000) X-34, a fluorescent derivative of Congo red: a novel histochemical stain for Alzheimer\u2019s disease pathology. J Histochem Cytochem 48:1223\u20131232","journal-title":"J Histochem Cytochem"},{"key":"943_CR48","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/j.1471-4159.2009.05996.x","volume":"109","author":"PW Thompson","year":"2009","unstructured":"Thompson PW, Ye L, Morgenstern JL, Sue L, Beach TG, Judd DJ, Shipley NJ, Libri V, Lockhart A (2009) Interaction of the amyloid imaging tracer FDDNP with hallmark Alzheimer\u2019s disease pathologies. J Neurochem 109:623\u2013630","journal-title":"J Neurochem"},{"key":"943_CR49","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1136\/jnnp.2008.171496","volume":"80","author":"VL Villemagne","year":"2009","unstructured":"Villemagne VL, McLean CA, Reardon K, Boyd A, Lewis V, Klug G, Jones G, Baxendale D, Masters CL, Rowe CC, Collins SJ (2009) 11C-PiB PET studies in typical sporadic Creutzfeldt\u2013Jakob disease. J Neurol Neurosurg Psychiatry 80:998\u20131001","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"943_CR50","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1097\/00002093-199910000-00009","volume":"13","author":"DS Wolf","year":"1999","unstructured":"Wolf DS, Gearing M, Snowdon DA, Mori H, Markesbery WR, Mirra SS (1999) Progression of regional neuropathology in Alzheimer disease and normal elderly: findings from the Nun study. Alzheimer Dis Assoc Disord 13:226\u2013231","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"943_CR51","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1097\/00004647-200212000-00004","volume":"22","author":"Y Wu","year":"2002","unstructured":"Wu Y, Carson RE (2002) Noise reduction in the simplified reference tissue model for neuroreceptor functional imaging. J Cereb Blood Flow Metab 22:1440\u20131452","journal-title":"J Cereb Blood Flow Metab"},{"key":"943_CR52","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2990.1986.tb00677.x","volume":"12","author":"T Yamamoto","year":"1986","unstructured":"Yamamoto T, Hirano A (1986) A comparative study of modified Bielschowsky, Bodian and thioflavin S stains on Alzheimer\u2019s neurofibrillary tangles. Neuropathol Appl Neurobiol 12:3\u20139","journal-title":"Neuropathol Appl Neurobiol"}],"container-title":["Acta Neuropathologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-012-0943-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00401-012-0943-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-012-0943-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,22]],"date-time":"2019-06-22T16:22:42Z","timestamp":1561220562000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00401-012-0943-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1,24]]},"references-count":52,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["943"],"URL":"https:\/\/doi.org\/10.1007\/s00401-012-0943-2","relation":{},"ISSN":["0001-6322","1432-0533"],"issn-type":[{"value":"0001-6322","type":"print"},{"value":"1432-0533","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,1,24]]}}}